Mineralys Therapeutics, Inc.'s total assets for Q1 2025 were $354.94M, an increase of 72.38% from the previous quarter. MLYS total liabilities were $13.39M for the fiscal quarter, a -8.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.